Novo Nordisk is pleased to report that all dose strengths of Wegovy® are now available to retail pharmacies nationwide. However, pharmacies may experience normal delays given the time required to order the product from their local distribution center, and geographical variabilities.
If you are interested in discussing Wegovy®, a prescription-only medicine, with your healthcare provider (HCP), we suggest you do so in the coming months as we continue to fill the supply chain. To determine if your insurance plan covers Wegovy®, you can visit Wegovy.com beginning January 3, 2023 or contact your insurance provider.
Novo Nordisk appreciates your interest in Wegovy®, and patience as we worked through supply challenges. Ensuring supply is available is a top priority. We are increasing our production capacity in 2023, closely monitoring prescribing trends and assessing demand.
We remain committed to driving meaningful change for people living with excess weight or obesity and supporting healthcare providers partnering on their care.
We are here to help and are ready to answer your questions at 1-833-4-WEGOVY (1-833-493-4689) from 9 AM to 6 PM Eastern Monday through Friday – and select option 0 for more support.